Autopsy report · NCT01079429

Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM.

“sponsor and investigator 's decision”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 2 months after it had already started.
• Ran for about 10 years 8 months before it stopped.
• 1,200 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Rennes University Hospital

Sponsor type

University, hospital or other

Conditions

Monoclonal Gammopathy of Undetermined Significance; Smoldering Myeloma

Interventions

Genetic study of DNA copies

Participants

1,200 (planned, not actual)

Sites

27

Countries

France

Trials that died the same way

• Unipolar Microplasma Radiofrequency Device: In-vivo Histologic Study
  “Per Investigator and sponsor decision” (92% match in meaning)
• The Effect of a Probiotic Strain on Aspirin-induced GI Damage
  “Decision made by Sponsor” (78% match in meaning)
• A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
  “Sponsor's Decision” (78% match in meaning)
• Bacteriophage Therapy in First Time Chronic Prosthetic Joint Infections
  “Sponsor Decision” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.